Sign in
Taking peopleNo phase

Comparative Analysis of Two Transforaminal Lumbar Interbody Fusion (TLIF) Procedures in the Treatment of Single-Level Lumbar Spinal Stenosis (LSS): A Single-Center, Prospective, Randomized Controlled Trial

Key facts

Who runs it
The Third Affiliated Hospital of Southern Medical University
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
276 people, planned
Started
18 Mar 2026
Expected to end
31 Dec 2031
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • LUSE-TLIF
  • MIS-TLIF
Record updated
14 May 2026

Who can take part

Age
40 years to 70 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • Age ranging from 40 to 70 years, irrespective of sex
  • Presence of bilateral lower-limb pain and neurogenic claudication, with or without low back pain
  • Preoperative computed tomography or magnetic resonance imaging confirming single-level lumbar spinal stenosis accompanied by grade II or higher lumbar spondylolisthesis and/or lumbar instability
  • Persistent pain within 7 days prior to enrollment, with inadequate response to nonsurgical treatment for more than 3 months
  • Willingness to provide written informed consent and ability to comply with the study protocol and visit schedule

Who cannot take part

  • Patients with a history of previous lumbar spine surgery
  • Known concurrent diseases considered by the investigator to preclude study entry
  • Coexistence of severe lumbar disc herniation, spinal deformity, spinal tumor, infection, or inflammatory diseases
  • Presence of severe underlying medical conditions or psychiatric disorders that preclude tolerance of the procedure
  • Patients with evidence of vascular claudication identified by lower-limb color Doppler ultrasound
  • Pregnancy or lactation
  • Inability to comply with study assessments or complete questionnaires for any reason
  • Patients deemed unsuitable for participation in this trial as judged by the investigator

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 40 and 70 years old?

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Lumbar spinal stenosis (LSS), a common degenerative lumbar condition characterized by low back pain, leg pain, and neurogenic claudication, significantly impairs patients' quality of life. Its prevalence continues to rise with the aging population. For patients who do not respond to conservative treatment, surgical intervention remains a key therapeutic approach, with lumbar interbody fusion (LIF) being a commonly employed procedure. The technique has evolved from posterior lumbar interbody fusion (PLIF) to transforaminal lumbar interbody fusion (TLIF) and, more recently, to minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF). Although MIS-TLIF can effectively reduce tissue trauma and complications, it still faces clinical challenges such as intraoperative visual blind spots and the potential for postoperative chronic back pain associated with reliance on conventional pedicle screws. To address these limitations, our research team independently developed a highly integrated, miniaturized (with an outer diameter of only 1.8 mm), and maneuverable L-Unitary Soft Endoscope (LUSE) minimally invasive system. Its unique design helps avoid obstruction of the surgical field and allows flexible adjustment during the procedure. Currently, there is a lack of clinical efficacy evaluations in China on the use of this LUSE system for TLIF surgery (referred to as LUSE-TLIF) in treating LSS. Therefore, this study aims to systematically compare LUSE-TLIF with the currently mainstream MIS-TLIF, evaluating its safety, efficacy, and clinical outcomes in the treatment of LSS, in order to provide spine surgeons with a novel and potentially superior minimally invasive surgical option.

The 2 groups in the trial

  • LUSE-TLIFTreatment being tested

    The subject underwent LUSE-TLIF surgery

  • MIS-TLIFExisting treatment, for comparison

    Subjects underwent MIS-TLIF surgery assisted by the Quadrant channel

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparative Analysis of L-Unitary Soft Endoscope Transforaminal Lumbar Interbody Fusion (LUSE-TLIF) Versus Minimally Invasive Transforaminal Lumbar Interbody Fusion (MIS-TLIF) in the Treatment of Single-Level Lumbar Spinal Stenosis (LSS): A Single-Center, Prospective, Randomized Controlled Trial
Criteria questions
Built from NCT07588555, who can take part
Record updated
14 May 2026